| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |